Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitals.

Alshekhlee A, Miles JD, Katirji B, Preston DC, Kaminski HJ.

Neurology. 2009 May 5;72(18):1548-54. doi: 10.1212/WNL.0b013e3181a41211.

PMID:
19414721
2.

Predictable recovery from myasthenia gravis crisis with plasma exchange: thirty-six cases and review of current management.

Mahalati K, Dawson RB, Collins JO, Mayer RF.

J Clin Apher. 1999;14(1):1-8. Review.

PMID:
10355656
3.

Myasthenia gravis: management of myasthenic crisis and perioperative care.

Juel VC.

Semin Neurol. 2004 Mar;24(1):75-81. Review.

PMID:
15229794
4.

[Epidemiology of myasthenia gravis].

Pekmezović T, Lavrnić D, Jarebinski M, Apostolski S.

Srp Arh Celok Lek. 2006 Sep-Oct;134(9-10):453-6. Review. Serbian.

5.

Juvenile myasthenia gravis.

Chiang LM, Darras BT, Kang PB.

Muscle Nerve. 2009 Apr;39(4):423-31. doi: 10.1002/mus.21195. Review.

PMID:
19229875
6.

The epidemiology of myasthenia gravis.

Phillips LH.

Semin Neurol. 2004 Mar;24(1):17-20. Review.

PMID:
15229788
7.

Lifetime course of myasthenia gravis.

Grob D, Brunner N, Namba T, Pagala M.

Muscle Nerve. 2008 Feb;37(2):141-9. Review.

PMID:
18059039
8.

Treatment strategies for myasthenia gravis.

Díaz-Manera J, Rojas-García R, Illa I.

Expert Opin Pharmacother. 2009 Jun;10(8):1329-42. doi: 10.1517/14656560902950619. Review.

PMID:
19445561
9.

[Contribution of intravenous immunoglobulins to the treatment of myasthenia].

Gajdos P.

Ann Med Interne (Paris). 2000 May;151 Suppl 1:1S30-4. Review. French.

PMID:
10896986
10.

Therapy of myasthenic crisis.

Berrouschot J, Baumann I, Kalischewski P, Sterker M, Schneider D.

Crit Care Med. 1997 Jul;25(7):1228-35. Review.

PMID:
9233752
11.

Epidemiology of myasthenia gravis.

Kurtzke JF.

Adv Neurol. 1978;19:545-66. Review. No abstract available.

PMID:
369334
12.

Myasthenia gravis: myasthenia vs. cholinergic crisis.

Hetherington KA, Losek JD.

Pediatr Emerg Care. 2005 Aug;21(8):546-8; quiz 549-51. Review.

PMID:
16096606
13.

[Prevalence of myasthenia gravis in Antioquia, Colombia].

Sánchez JL, Uribe CS, Franco AF, Jiménez ME, Arcos-Burgos OM, Palacio LG.

Rev Neurol. 2002 Jun 1-15;34(11):1010-2. Review. Spanish.

14.

Myasthenic crisis: guidelines for prevention and treatment.

Jani-Acsadi A, Lisak RP.

J Neurol Sci. 2007 Oct 15;261(1-2):127-33. Epub 2007 Jun 4. Review.

PMID:
17544450
15.

Medical therapies in myasthenia gravis.

Younger DS, Raksadawan N.

Chest Surg Clin N Am. 2001 May;11(2):329-36. Review.

PMID:
11413759
16.

[Therapeutic strategy in myasthenia gravis].

Tranchant C.

Rev Neurol (Paris). 2009 Feb;165(2):149-54. doi: 10.1016/j.neurol.2009.01.005. Review. French.

PMID:
19233080
17.

[Myasthenic crisis during pregnancy: case report and literature survey].

Kwieciński H, Janik P, Lyzwa-Prawecka M, Strugalska H, Pniewski J.

Pol Tyg Lek. 1995 Oct;50(40-44):50-2. Review. Polish.

PMID:
8650062
18.

[Antibodies in myasthenia gravis].

Eymard B.

Rev Neurol (Paris). 2009 Feb;165(2):137-43. doi: 10.1016/j.neurol.2008.11.020. Epub 2009 Jan 21. Review. French.

PMID:
19162288
19.

A systematic review of population based epidemiological studies in Myasthenia Gravis.

Carr AS, Cardwell CR, McCarron PO, McConville J.

BMC Neurol. 2010 Jun 18;10:46. doi: 10.1186/1471-2377-10-46. Review.

20.

Epidemiology of myasthenia gravis.

Cohen MS.

Monogr Allergy. 1987;21:246-51. Review. No abstract available.

PMID:
3316998

Supplemental Content

Support Center